Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares RepurchasedShort-Term Debt repayments
Ratios

Avanos Medical (AVNS) Short-Term Debt repayments (2016 - 2025)

Avanos Medical's Short-Term Debt repayments history spans 6 years, with the latest figure at $25.0 million for Q4 2024.

  • For Q4 2024, Short-Term Debt repayments fell 73.68% year-over-year to $25.0 million; the TTM value through Dec 2024 reached $45.0 million, down 60.87%, while the annual FY2025 figure was $25.0 million, 44.44% down from the prior year.
  • Short-Term Debt repayments for Q4 2024 was $25.0 million at Avanos Medical, up from $10.0 million in the prior quarter.
  • Across five years, Short-Term Debt repayments topped out at $130.0 million in Q2 2022 and bottomed at -$55.0 million in Q4 2021.
  • The 5-year median for Short-Term Debt repayments is $20.0 million (2022), against an average of $25.8 million.
  • The largest annual shift saw Short-Term Debt repayments tumbled 1200.0% in 2021 before it skyrocketed 1200.0% in 2022.
  • A 5-year view of Short-Term Debt repayments shows it stood at $5.0 million in 2020, then crashed by 1200.0% to -$55.0 million in 2021, then skyrocketed by 136.36% to $20.0 million in 2022, then skyrocketed by 375.0% to $95.0 million in 2023, then plummeted by 73.68% to $25.0 million in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Short-Term Debt repayments are $25.0 million (Q4 2024), $10.0 million (Q3 2024), and $10.0 million (Q1 2024).